Diagnos Historical Cash Flow
| ADK Stock | CAD 0.30 0.02 7.14% |
Analysis of Diagnos cash flow over time is an excellent tool to project Diagnos future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 400.1 K or Depreciation of 122 K as it is a great indicator of Diagnos ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Diagnos latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Diagnos is a good buy for the upcoming year.
Diagnos |
About Diagnos Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Diagnos balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Diagnos's non-liquid assets can be easily converted into cash.
Diagnos Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Diagnos to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Diagnos operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Diagnos' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Diagnos current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Diagnos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Diagnos' Change In Working Capital is fairly stable compared to the past year. Begin Period Cash Flow is likely to climb to about 400.1 K in 2025, whereas Free Cash Flow is likely to drop (2.3 M) in 2025.
Diagnos cash flow statement Correlations
Click cells to compare fundamentals
Diagnos Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Diagnos cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (211.1K) | 61.5K | (124.3K) | (77.6K) | (89.3K) | (84.8K) | |
| Free Cash Flow | (1.4M) | (2.1M) | (1.9M) | (2.4M) | (2.2M) | (2.3M) | |
| Change In Working Capital | 305.1K | (15.0K) | 87.1K | 153.6K | 176.7K | 185.5K | |
| Begin Period Cash Flow | 570.4K | 359.4K | 420.9K | 296.6K | 341.1K | 400.1K | |
| Other Cashflows From Financing Activities | 22.4K | 977.9K | (118.4K) | (14.0K) | (16.1K) | (15.3K) | |
| Depreciation | 87.4K | 105.8K | 101.2K | 124.2K | 142.8K | 122.0K | |
| Other Non Cash Items | 32.4K | 30.5K | 123.0K | 522.9K | 601.3K | 351.0K | |
| Capital Expenditures | 42.2K | 31.0K | 24.2K | 10.9K | 9.8K | 9.3K | |
| Total Cash From Operating Activities | (1.4M) | (2.0M) | (1.9M) | (2.4M) | (2.2M) | (2.3M) | |
| Net Income | (2.1M) | (2.6M) | (2.5M) | (3.1M) | (2.8M) | (2.9M) | |
| Total Cash From Financing Activities | 882.8K | 1.6M | 1.3M | 2.3M | 2.7M | 1.8M | |
| End Period Cash Flow | 359.4K | 420.9K | 296.6K | 219.0K | 251.9K | 381.1K | |
| Stock Based Compensation | 251.9K | 426.1K | 167.3K | 178.2K | 205.0K | 208.5K | |
| Change To Account Receivables | 139.7K | (142.2K) | 83.0K | 96.7K | 111.2K | 116.8K | |
| Investments | 300K | 530K | 500K | (14.0K) | (16.1K) | (15.3K) | |
| Net Borrowings | 467.8K | (206.8K) | 894.9K | 1.4M | 1.3M | 743.7K | |
| Total Cashflows From Investing Activities | (760.0K) | 262.9K | 503.5K | 474.7K | 545.9K | 573.2K | |
| Change To Operating Activities | (113.9K) | 96.2K | 4.5K | 6.8K | 6.1K | 9.6K | |
| Other Cashflows From Investing Activities | 16.8K | 5.1K | 4.5K | (1.0K) | (944.1) | (896.89) | |
| Change To Netincome | 660.7K | 296.5K | 479.5K | 394.2K | 453.4K | 630.4K | |
| Change To Liabilities | 46.7K | 69.3K | 122.8K | (2.6K) | (3.0K) | (2.8K) | |
| Issuance Of Capital Stock | 1.1M | 723.8K | 447.4K | 1.6M | 1.5M | 1.2M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.